Skip to Main Content

Paper Details

Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells.
Science
905
2015
Cancer, HLA-A*02:01, T cell receptor, TCR, advanced melanoma, amino acid, dendritic cell vaccine, human, human leukocyte antigen (HLA) class I, melanoma, melanoma neoantigen-specific T cells, patient, patients, tumor
Author NameAffiliation
Vincent MagriniGenome Institute, Washington University School of Medicine
Saghar KaabinejadianUniversity of Oklahoma Health Science Center
Jasreet HundalGenome Institute, Washington University School of Medicine
William H HildebrandUniversity of Oklahoma Health Science Center
Elaine R MardisGenome Institute, Washington University School of Medicine
Elaine R MardisGenome Institute, Washington University School of Medicine
  • 1 - 6

Datasets

Release 1.2